Agreements & Licences

Agreements & Licences
English

Patent license deal monoclonal antibodies between a Dutch biotechnology company and an international pharmaceutical company (2014)

We have advised a fast growing Ducth biotech company in a complex patent and know-how license deal, with regard to proprietary monoclonal antibodies, with one of the largest international pharmaceutical companies worldwide (2014). We have assisted our client in preparing the deal terms, inter alia with the selection and presentation of information, provided an opinion on the validity of patents of third parties and negotiated the contract. 

Advising a national scientific institute and renegotiating a patent licence with a Dutch start-up in the field of DNA technology (2014)

In this case, for a national Dutch scientific institute, we terminated old technology transfer and patent license agreements in the field of DNA technology, that they had concluded with a Ducth start-up company. We formulated new agreements in a clearer, more transparent way, overseeing the negotiation process. 

 

 

Advising on technology transfer contracts for a national institution in the field of vaccine research and development (2014)

For our client, we negotiated a number of major licence contracts with Asian licensees in the field of vaccine research and development, focusing in particular on product liability, general liability and the enforceability of royalty payments. 

Drafting and evaluating study sponsor agreements for an international pharmaceutical company (2014)

Many factors come into place, including compliance with regulations, not just in the sphere of pharmaceutical law but also with regard to financial arrangements with doctors and the transparency of those arrangements, intellectual property, publication of results, liability and scientific integrity. 

Drafting and evaluating study sponsor agreements for an international pharmaceutical company (2014)

Many factors come into play, including compliance with regulations, not just in the sphere of pharmaceutical law but also with regard to financial arrangements and the transparency of those arrangements, intellectual property, publication of results, liability and scientific integrity. 

Advising on the introduction of software-supported medicinal use (2014)

Increasingly complex (biotechnology) pharmaceuticals are supported by medical devices and apps offered by the pharmaceutical manufacturer. Their supply to doctors and hospitals and the use of these devices by doctors and patients is heavily regulated: from licences to use mainly web-based technology and liability for the accuracy of data to the protection of patient privacy and regulations on inducements (Code for Pharmaceutical Advertising). We drew up terms and conditions and contracts, so that the programme can be used correctly.

Subscribe to RSS - Agreements & Licences